MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia
Abstract Outcomes for pediatric acute myeloid leukemia (AML) have improved significantly in recent years. However, relapsed and refractory disease remains a significant problem. The chemotherapy burden experienced by these patients makes the translational development of non-genotoxic experimental th...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2026-05-01
|
| coleção: | Cell Death and Disease |
| Acesso em linha: | https://doi.org/10.1038/s41419-026-08847-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
